Evaluation of a blood-based geroscience biomarker index in a randomized trial of caloric restriction and exercise in older adults with heart failure with preserved ejection fraction

被引:0
|
作者
Jamie N. Justice
Nicholas M. Pajewski
Mark A. Espeland
Peter Brubaker
Denise K. Houston
Santica Marcovina
Barbara J. Nicklas
Stephen B. Kritchevsky
Dalane W. Kitzman
机构
[1] Wake Forest School of Medicine,Department of Internal Medicine, Section On Gerontology and Geriatric Medicine
[2] Wake Forest School of Medicine,Department of Biostatistics and Data Science
[3] Forest University in Winston-Salem,Department of Health and Exercise Science at Wake
[4] Medpace Reference Laboratories,undefined
[5] Department of Internal Medicine,undefined
[6] Section On Cardiology,undefined
[7] Wake Forest School of Medicine,undefined
来源
GeroScience | 2022年 / 44卷
关键词
Physical performance; Cardiac; Diet; Intervention; Aging;
D O I
暂无
中图分类号
学科分类号
摘要
Intermediate endpoints are needed to evaluate the effect of interventions targeting the biology of aging in clinical trials. A working group identified five blood-based biomarkers that may serve such a purpose as an integrated index. We evaluated the responsiveness of the panel to caloric restriction or aerobic exercise in the context of a randomized clinical trial conducted in patients with heart failure with preserved ejection fraction (HFpEF) with obese phenotype who were predominantly female. Obese HFpEF is highly prevalent in women, and is a geriatric syndrome whose disease pathology is driven by non-cardiac factors and shared drivers of aging. We measured serum Interleukin-6, TNF-α-receptor-I, growth differentiating factor-15, cystatin C, and N-terminal pro-b-type natriuretic peptide at baseline and after 20 weeks in older participants with stable obese HFpEF participating in a randomized, controlled, 2 × 2 factorial trial of caloric restriction and/or aerobic exercise. We calculated a composite biomarker index, summing baseline quintile scores for each biomarker, and analyzed the effect of the interventions on the index and individual biomarkers and their associations with changes in physical performance. This post hoc analysis included 88 randomized participants (71 women [81%]). The mean ± SD age was 66.6 ± 5.3 years, and body mass index (BMI) was 39.3 ± 6.3 kg/m2. Using mixed models, mean values of the biomarker index improved over 20 weeks with caloric restriction (− 0.82 ±\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\pm$$\end{document} 0.58 points, p = 0.05), but not with exercise (− 0.28 ±\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\pm$$\end{document} 0.59 points, p = 0.50\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$0.50$$\end{document}), with no evidence of an interaction effect of CR ×\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\times$$\end{document} EX ×\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\times$$\end{document} time (p = 0.80) with adjustment for age, gender, and BMI. At baseline, the biomarker index was inversely correlated with 6-min walk distance, scores on the short physical performance battery, treadmill test peak workload and exercise time to exhaustion (all ρ\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\rho$$\end{document}s = between − 0.21 and − 0.24). A reduction in the biomarker index was also associated with increased 4-m usual walk speed (ρ\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\rho$$\end{document}s =  − 0.31). Among older patients with chronic obese HFpEF, caloric restriction improved a biomarker index designed to reflect biological aging. Moreover, the index was associated with physical performance and exercise tolerance.
引用
收藏
页码:983 / 995
页数:12
相关论文
共 50 条
  • [21] Randomized Double-Blind Trial of Enalapril in Older Patients With Heart Failure and Preserved Ejection Fraction
    Kitzman, Dalane W.
    Hundley, W. Gregory
    Brubaker, Peter H.
    Morgan, Timothy M.
    Moore, J. Brian
    Stewart, Kathryn P.
    Little, William C.
    CIRCULATION-HEART FAILURE, 2010, 3 (04) : 477 - 485
  • [22] Sleep disordered breathing in older adults with heart failure with preserved ejection fraction
    Baniak, Lynn M.
    Chasens, Eileen R.
    GERIATRIC NURSING, 2018, 39 (01) : 77 - 83
  • [23] NEUROHORMONAL BLOCKADE AND OUTCOMES IN OLDER ADULTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
    不详
    GERONTOLOGIST, 2012, 52 : 722 - 722
  • [24] Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults
    Hashemi, Ashkan
    Kwak, Min Ji
    Goyal, Parag
    DRUGS & AGING, 2025, 42 (02) : 95 - 110
  • [25] Potassium Nitrate in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
    Zamani, Payman
    Shah, Sanjiv J.
    Cohen, Jordana B.
    Zhao, Manyun
    Yang, Wei
    Afable, Jessica L.
    Caturla, Maria
    Maynard, Hannah
    Pourmussa, Bianca
    Demastus, Cassandra
    Mohanty, Ipsita
    Miyake, Michelle Menon
    Adusumalli, Srinath
    Margulies, Kenneth B.
    Prenner, Stuart B.
    Poole, David C.
    Wilson, Neil
    Reddy, Ravinder
    Townsend, Raymond R.
    Ischiropoulos, Harry
    Cappola, Thomas P.
    Chirinos, Julio A.
    JAMA CARDIOLOGY, 2025, 10 (03) : 284 - 289
  • [26] Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial
    Gavin A. Lewis
    Susanna Dodd
    Dannii Clayton
    Emma Bedson
    Helen Eccleson
    Erik B. Schelbert
    Josephine H. Naish
    Beatriz Duran Jimenez
    Simon G. Williams
    Colin Cunnington
    Fozia Zahir Ahmed
    Anne Cooper
    Stuart Rajavarma Viswesvaraiah
    Theresa Russell
    Paula R. McDonagh
    Christopher A. Williamson
    Nature Medicine, 2021, 27 : 1477 - 1482
  • [27] Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial
    Lewis, Gavin A.
    Dodd, Susanna
    Clayton, Dannii
    Bedson, Emma
    Eccleson, Helen
    Schelbert, Erik B.
    Naish, Josephine H.
    Jimenez, Beatriz Duran
    Williams, Simon G.
    Cunnington, Colin
    Ahmed, Fozia Zahir
    Cooper, Anne
    Viswesvaraiah, Rajavarma
    Russell, Stuart
    McDonagh, Theresa
    Williamson, Paula R.
    Miller, Christopher A.
    NATURE MEDICINE, 2021, 27 (08) : 1477 - +
  • [28] Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction JACC State-of-the-Art Review
    Pandey, Ambarish
    Shah, Sanjiv J.
    Butler, Javed
    Kellogg, Dean L.
    Lewis, Gregory D.
    Forman, Daniel E.
    Mentz, Robert J.
    Borlaug, Barry A.
    Simon, Marc A.
    Chirinos, Julio A.
    Fielding, Roger A.
    Volpi, Elena
    Molina, Anthony J. A.
    Haykowsky, Mark J.
    Sam, Flora
    Goodpaster, Bret H.
    Bertoni, Alain G.
    Justice, Jamie N.
    White, James P.
    Ding, Jingzhone
    Hummel, Scott L.
    LeBrasseur, Nathan K.
    Taffet, George E.
    Pipinos, Iraklis I.
    Kitzman, Dalane
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 78 (11) : 1166 - 1187
  • [29] Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction
    Shaltout, Hossam A.
    Eggebeen, Joel
    Marsh, Anthony P.
    Brubaker, Peter H.
    Laurienti, Paul J.
    Burdette, Jonathan H.
    Basu, Swati
    Morgan, Ashley
    Dos Santos, Patricia C.
    Norris, James L.
    Morgan, Timothy M.
    Miller, Gary D.
    Rejeski, W. Jack
    Hawfield, Amret T.
    Diz, Debra I.
    Becton, J. Thomas
    Kim-Shapiro, Daniel B.
    Kitzman, Dalane W.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2017, 69 : 78 - 90
  • [30] Exercise Stress Echocardiography in the Diagnostic Evaluation of Heart Failure with Preserved Ejection Fraction
    Harada, Tomonari
    Kagami, Kazuki
    Kato, Toshimitsu
    Ishii, Hideki
    Obokata, Masaru
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (03)